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Abstract 
Secondary,  radiation-induced  neoplasms
represent  a  significant  long-term  risk  after
radiation  treatment,  and  radiation-induced
sarcomas (RAS) have an especially poor prog-
nosis. These have rarely been reported after
irradiation for pituitary adenomas. 
Case Report
A 62 year old male presented with confusion,
lethargy, diffuse weakness, worsening vision,
and a 32 kg unintentional weight loss over a
one-year period. Physical exam findings includ-
ed a complete left ophthalmoplegia with propto-
sis, as well as a right sixth nerve palsy and left
trigeminal sensory disturbance. He had previ-
ously undergone a left frontotemporal cranioto-
my for resection of pituitary adenoma 25 years
ago,  with  adjuvant  external  beam  radiation
treatment estimated to be between 45-54 Gy.
After surgery and radiation therapy, the patient
experienced panhypopituitarism and was treat-
ed with stable doses of prednisone, levothyrox-
ine, and topical testosterone until the current
presentation.  He  was  admitted  to  a  general
medical  service  for  his  complaints,  and  was
found to be hypovolemic. With volume reple-
tion, the patient was found to be hypernatrem-
ic, with 3-7 L of urine output per day. Although
he had not previously required treatment with
desmopressin,  laboratory  findings  supported
the  diagnosis  of  central  diabetes  insipidus
requiring ongoing desmopressin use.
Because of this new presentation and his
previous history, cranial magnetic resonance
imaging  (MRI)  was  obtained.  This  demon-
strated a destructive soft tissue mass extend-
ing from the sella into the suprasellar cistern
(Figure 1A), extending medially from the sphe-
noid sinus through the cavernous sinus into
the medial anterior cranial fossa with associat-
ed  bony  erosion  (Figure  1F)  and  vasogenic
edema in the underlying temporal lobe (Figure
1B).  Initial  MRI  was  done  without  contrast,
due to patients inability to continue, with the
imaging  appearance  concerning  for  a  skull
base neoplasm which was thought to possibly
be  secondarily  infected  due  to  the  central
region of restricted diffusion adjacent to the
temporal  lobe  (Figure  1D,E).  Follow  up
gadolinium-enhanced  images  (Figure  1C)
showed the lesion to have solid heterogenous
enhancement in the sphenoid sinus but thick
peripheral  enhancement  in  the  region  of
restricted diffusion in the middle cranial fossa.
The imaging was most consistent with a recur-
rent tumor, possibly a high-grade, radiation-
induced  tumor,  with  possible  secondary
abscess formation. Neurosurgical consultation
was obtained, and a re-do left frontotemporal
craniotomy was performed for partial resection
and for biopsy to obtain definitive diagnosis. A
transsphenoidal procedure was contemplated
and would have allowed access to the tumor in
the  central  skull  base  but  would  not  have
allowed access to the area in the temporal lobe
concerning for infection. Upon extradural dis-
section, the anterior clinoid was found to be
eroded by tumor, with multiple foci of extradur-
al tumor extension obviously visible along the
middle  cranial  fossa.  Intradural  dissection
revealed complete encasement of the left optic
nerve and cavernous carotid artery by tumor.
Multiple biopsies were taken for pathology and
culture analysis.
No evidence of abscess cavity was identified
and  all  cultures  obtained  were  negative  for
bacterial  or  fungal  growth.  Pathology  con-
firmed grade 4 (of 4) spindle cell sarcoma from
all surgical specimens. Immunohistochemical
studies confirmed the diagnosis, demonstrat-
ing CD34 positive staining, while S-100, SMA
and desmin were negative. MIB-1 demonstrat-
ed  a  moderately  brisk  proliferation  rate.
Reticulin stained positive (Figure 2A, D).
The  patient  awoke  post-operatively  to  his
preoperative  neurologic  baseline;  moving  all
extremities  and  alert  but  confused.
Nevertheless, his clinical course quickly dete-
riorated during the post-operative period. After
compassionate discussion regarding the poor
prognosis, the patient’s family elected to with-
draw aggressive care in favor of maximal com-
fort measures, and he expired on post-opera-
tive day 15.
Discussion
Radiation-induced  tumors  were  originally
described by Cahan in 1948, who also outlined
four prerequisites for a tumor to be classified
as such.1 These include tumor location in a
previously radiated area, pathologically-proven
difference between the new tumor and the pri-
mary lesion, time lapse between radiation and
tumor development, and lastly no other predis-
posing conditions to tumor development.1
RAS are well-known to arise after ionizing
radiation  and  have  been  characterized  after
radiation treatment for a number of primary
neoplasms.  In  a  retrospective  review  of  160
patients  diagnosed  with  radiation-associated
sarcomas,  26%  were  following  treatment  for
breast cancer, 25% after lymphoma, and 14%
after treatment for carcinoma of the cervix.2
RAS  can  demonstrate  a  variety  of  histologic
subtypes; in a previous series, 87% of tumors
were  high  grade,  and  histologic  variations
included osteogenic, fibrous histiocytoma, and
angiosarcoma.2 Others  have  found  that  RAS
frequently  demonstrate  rearrangements  of
chromosome 3p,3 but regardless of histologic
subtype,  a  key  prognostic  factor  has  been
extent of surgical resection.2
RAS in the sellar region after irradiation for
pituitary  adenoma  is  a  known  entity  which
often  demonstrates  rapid  growth  and  an
aggressive  clinical  course  similar  to  RAS  in
other locations. A previously published, retro-
spective  review  of  all  reported  cases  only
uncovered 52 such neoplasms reported in the
literature, including those occurring after radi-
ation for craniopharyngiomas in 2 patients.4
The most common histologic types in the sell-
ar region have been fibrosarcoma, spindle cell
tumor,  and  high-grade  or  undifferentiated
fibrous  sarcoma.4 Latency  from  radiation  to
time of diagnosis ranged from 5-20 years,4 a
somewhat shorter timeframe than that experi-
enced by our patient. That previous review also
noted a steep rise in incidence of these neo-
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plasms occurred 5-13 years after radiation, and
a mortality of approximately 60% at 6 months.4
Symptom presentation was generally visual or
oculomotor complaints,4 which were noted in
our  patient;  hormonal  or  electrolyte  distur-
bances found in our patient are less commonly
reported. 
Because  of  the  rarity  of  this  lesion,  its
appearance on radiographic imaging has not
been  well-characterized  and  differentiating
factors of its radiographic appearance have not
been previously described. Of the 52 previous
case reports present in the literature regarding
RAS  after  treatment  for  pituitary  adenomas,
approximately twenty of these were reported
prior to the computed tomography (CT) era.
Those which did report CT findings, found pos-
itive contrast enhancement and bony erosion
of the skull base.5-8 Of the more recent case
reports during which MRI was available, only
six  report  imaging  characteristics  in  this
modality, describing an appearance character-
istic of other high-grade lesions such as con-
trast enhancement and invasion of surround-
ing structures.4,9-13 One series of two patients
presents  magnetic  resonance  spectroscopy
findings of increased metabolic activity within
the lesion,9 which is also non-specific for high
grade lesions. In the case of our patient, imag-
ing  included  a  diffusion  weighted  imaging
sequence  which  was  notable  for  showing
restricted diffusion of the tumor, which led to
initial concern about the possible presence of
an  abscess.  Other  features  that  were  worri-
some for high-grade tumor included: enhance-
ment,  marked  increase  in  size  over  a  short
interval, and a new increased T1 signal, which
could  have  been  associated  with  subacute
blood or proteinaceous fluid. These findings
could have been seen in radiation necrosis, but
as  restriction  of  diffusion  weighted  images
develops  around  the  peripheral  zone  of
enhancement,  this  is  more  suggestive  of
increase  cellularity  as  the  tumor  is  growing
peripherally. With this initial uncertainty, this
prompted  more  urgent  surgical  exploration,
although no evidence of infection was found to
be present. 
RAS after sellar radiation for pituitary ade-
noma is a disease with a dismal prognosis due
to its rapid growth and aggressive invasion of
surrounding  critical  structures.  No  reported
current treatment modalities have been effec-
tive. En bloc resection, a central tenet of sarco-
ma management, is generally impossible due
to  invasion  of  structures  such  as  the  optic
nerve, cavernous sinus, and internal carotid
artery. These lesions may be under-diagnosed
because of their propensity to invade the struc-
tures of the skull base and cause sudden death,
with several patients in the literature present-
ing with fatal hemispheric stroke or intratu-
moral hemorrhage. A diagnostic clue may be
the  late  development  of  diabetes  insipidus,
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Figure 1. Radiographic images of a radiation-induced sarcoma. A) Sagittal T1 demon-
strates a heterogeneous sella mass extending from the sphenoid sinus (white arrowhead)
into the hypothalamus and suprasellar cistern (white arrow); B) axial FSE T2 demon-
strates the sphenoid component to be heterogenously hypointense (white arrowhead)
extending into the cavernous sinus encasing the carotid (white arrow). The intracranial
component is extraaxial and hyperintense with a rim of hypointensity (black arrowhead).
Associated vasogenic edema in the underlying temporal lobe (black arrow). C) Axial T1
with gadolinium demonstrates solid enhancement (white arrowhead) in the extracranial
portion with thick rim enhancement intracranially (black arrow); D) axial DWI (B1500)
and E) ADC map both demonstrate restricted diffusion within the peripherally enhanc-
ing component; F) axial computed tomography bone window demonstrates bony erosion
through the sphenoid (white arrow)
Figure 2. Histopathology of resected tumor demonstrates a high grade sarcoma. A) The
tumor is a highly cellular, spindle cell sarcoma (hematoxylin and eosin magnification
x200) and is highly mitotically active (B, hematoxylin and eosin, magnification x400).
The tumor cells stain with antibodies to CD34 (C, magnification x400), and show a peri-
cellular reticulin staining pattern (D, magnification x400). Immunostains for S100 pro-
tein and desmin were negative (not shown). [page 20] [Rare Tumors 2012; 4:e7]
which is rare with pituitary adenoma recur-
rence  and  may  suggest  a  more  aggressive
lesion invading the posterior pituitary, prompt-
ing earlier investigation. 
Although rare, the incidence of RAS is likely
to increase with increasing use of radiation
therapy  for  pituitary  adenomas,  as  well  as
other histologically benign intracranial lesions
such as schwannomas and skull base menin-
giomas.  Physicians  treating  patients  with  a
history of sellar radiation for pituitary adeno-
mas or other sellar tumors must be cognizant
of this late post-radiation complication.
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